SAPHNELO
NDC 0310-3040, Anifrolumab-fnia, injection, solution, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-3040
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761123
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANIFROLUMAB300 mg/2mL
Pharmacologic classes
Type I Interferon Receptor Antagonist [EPC]; Type I Interferon Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-3040-00 | 00310304000 | 1 VIAL, GLASS in 1 CARTON (0310-3040-00) / 2 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d6203302-2128-41a7-b0b4-0e6c0704d4dcMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0310-3040
Use it
Look up 0310-3040 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3040 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-3040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.